Related Experiment Video
Updated: Jun 9, 2026
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Ipsilateral breast tumor recurrence after breast-conserving therapy
Valerie Panet-Raymond1, Pauline T Truong, Peter H Watson
1British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada.
Expert Review of Anticancer Therapy
|August 26, 2010
Summary
Distinguishing true breast cancer recurrences from new primary tumors after breast-conserving surgery is crucial. Understanding these differences helps in personalizing treatment for patients experiencing ipsilateral breast tumor recurrence (IBTR).
Area of Science:
- Oncology
- Breast Cancer Research
- Surgical Pathology
Background:
- Ipsilateral breast tumor recurrence (IBTR) is a growing clinical challenge following breast-conserving therapy for early-stage breast cancer.
- IBTR can manifest as either true recurrences (regrowth of initial disease) or new primary tumors, potentially with different characteristics.
- The distinct biologies and survival prognoses of these two IBTR types require further clarification.
Purpose of the Study:
- To examine current clinical and pathological methods for differentiating true recurrences from new primary breast tumors.
- To review published data from prospective and retrospective studies on distinguishing IBTR subtypes.
- To discuss challenges and future directions for a standardized classification system for IBTR.
Main Methods:
- Review of contemporary clinical and pathological diagnostic techniques.
- Analysis of published prospective and retrospective study data.
- Discussion of existing challenges in classifying IBTR.
Main Results:
- Current methods for distinguishing true recurrences from new primaries are being examined.
- Published data provide insights into the characteristics of different IBTR types.
- Challenges remain in establishing a universally accepted classification system.
Conclusions:
- Accurate differentiation of true recurrences versus new primaries is essential for patient management after breast-conserving surgery.
- Further research is needed to develop a standardized, reproducible classification system for IBTR.
- Such a system will aid in prognostication and personalized treatment strategies for in-breast recurrences.
